{
  "meta": {
    "title": "Malabsorption_Syndromes_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/malabsorption-syndromes-mini-test-tmt-ff0e6905.html",
    "scrapedAt": "2025-11-30T12:47:07.307Z"
  },
  "questions": [
    {
      "text": "A 10-year-old child is brought for evaluation of repeated lung infections. The bronchial fluid samples show gram-negative, oxidase-positive bacteria that produce a bluish-green pigment. He also has been experiencing foul-smelling diarrhea with pale, floating stools. What is the mode of inheritance of the condition that the child is most likely to have?",
      "choices": [
        {
          "id": 1,
          "text": "Mitochondrial"
        },
        {
          "id": 2,
          "text": "X-linked dominant"
        },
        {
          "id": 3,
          "text": "Autosomal recessive"
        },
        {
          "id": 4,
          "text": "Autosomal dominant"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Repeated lung infections</strong> and <strong>steatorrhea</strong> (foul-smelling diarrhea with pale, floating stools) suggest a diagnosis of<strong> cystic fibrosis.</strong>&nbsp;It has an <strong>autosomal recessive</strong> inheritance pattern.&nbsp;Gram-negative, oxidase-positive bacteria that produce a blue-green pigment indicate infection with&nbsp;<em><strong>Pseudomonas aeruginosa</strong>,&nbsp;</em>which is commonly seen in this condition.&nbsp;</p><p>Cystic fibrosis is an inherited disorder due to a mutation in the <strong>cystic fibrosis transmembrane conductance regulator (<em>CFTR</em>) gene</strong> located on <strong>chromosome 7</strong> (7q31.2). It leads to abnormal transport of chloride and bicarbonate ions in the lungs, gastrointestinal tract, pancreas, and reproductive tract.&nbsp;</p>\n<ul>\n<li>Lungs - Abnormal CFTR leads to sticky viscous mucus with abnormal mucociliary clearance leading to obstruction and <strong>recurrent respiratory infections</strong>.&nbsp;</li>\n<li>Pancreas - The viscous secretions <strong>block</strong> the <strong>pancreatic</strong> <strong>ducts</strong> impairing the flow of digestive enzymes. This leads to <strong>exocrine pancreatic insufficiency</strong>,<strong>&nbsp;</strong>causing fat malabsorption and the resultant steatorrhea.&nbsp;</li>\n<li>Reproductive tract - More than 95% of men are infertile, with&nbsp;<strong>absent vas deferens</strong>. Women have tenacious cervical mucus but are not always infertile.&nbsp;</li>\n</ul>\n<p>The <strong>sweat</strong>&nbsp;<strong>chloride</strong>&nbsp;<strong>test </strong>is used to confirm the diagnosis of cystic fibrosis.<strong>&nbsp;</strong>Sweat ducts with normal CFTR reabsorb the chloride from the primary sweat secretion. Mutated CFTR reduces this uptake, increasing chloride levels in sweat.<strong>&nbsp;</strong>A sweat chloride level of&nbsp;<strong>&gt;60 mmol/L</strong>&nbsp;is diagnostic.</p>\n<p>Other pathogens commonly causing infections in cystic fibrosis include <em>Staphylococcus aureus</em>, <em>Haemophilus influenzae</em>, and&nbsp;<em>Burkholderia cepacia</em>.&nbsp;</p><hr><h3>Related Pearl: Inheritance pattern of important diseases</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington&rsquo;s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher&rsquo;s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don&rsquo;t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch&ndash;Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett&rsquo;s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot&ndash;Marie&ndash;Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on&rsquo;t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott&ndash;Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>&nbsp;</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7827",
      "difficulty": "easy"
    },
    {
      "text": "You are evaluating a 39-year-old male patient for malabsorption and vitamin B12 deficiency. He undergoes a Schilling test and the findings observed are given in the table. What is the likely diagnosis?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Test</strong></td>\n<td><strong>Absorption</strong></td>\n</tr>\n<tr>\n<td>Co-labeled cobalamin</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td>With intrinsic factor</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>With pancreatic enzymes</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td>With Antibiotics for 5 days</td>\n<td>Reduced</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Pernicious anemia"
        },
        {
          "id": 2,
          "text": "Ileal disease"
        },
        {
          "id": 3,
          "text": "Small intestinal bacterial overgrowth (SIBO)"
        },
        {
          "id": 4,
          "text": "Chronic pancreatitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Normal absorption of Vit B12 with intrinsic factor is seen in&nbsp;<strong>Pernicious Anemia.</strong></p>\n<p>Pernicious anemia can be defined as a severe lack of intrinsic factor due to gastric atrophy. People who have pernicious anemia can't absorb enough vitamin B12 from food. This is because they lack intrinsic factor, a protein made in the stomach.&nbsp;</p><hr><h3>Related Pearl: Schilling Test</h3><p>The Schilling test is done to determine the <strong>cause</strong> of <strong>vitamin B12 deficiency.</strong> It involves the administration of radiolabeled vitamin B12&nbsp;followed by the 24-hour&nbsp;collection of urine. The test is then repeated with an&nbsp;additional component&nbsp;that can promote vitamin B12 absorption.&nbsp;If the additional component is able to correct the defect and radiolabeled vitamin B12 is absorbed, it will be detected in the urine.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5d3f9735577a4affb67cd119f1540ba0x1280x2246.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3904",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with fatigue and chronic diarrhea for 4 months. Endoscopy reveals several ulcers in the gastric antrum and the descending duodenum. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "VIPoma"
        },
        {
          "id": 2,
          "text": "Zollinger-Ellison syndrome"
        },
        {
          "id": 3,
          "text": "Glucagonoma"
        },
        {
          "id": 4,
          "text": "Insulinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of gastrinoma- <strong>Zollinger-Ellison</strong> <strong>syndrome</strong>. </p>\n<div class=\"page\" title=\"Page 776\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Zollinger-Ellison syndrome is caused by <strong>gastrin-secreting neuroendocrine tumors</strong>. In 75% of patients, gastrinomas are sporadic, solitary lesions. The remaining 25% of patients with gastrinomas have multiple endocrine neoplasia type 1 (MEN1). Gastrinomas usually arise in the small intestine or pancreas. The most remarkable feature in the stomach is an<strong> increase in oxyntic mucosal thickness</strong> due to massive parietal cell hyperplasia.</p>\n<p>Patients present with <strong>duodenal ulcers</strong> or <strong>chronic diarrhea</strong>. The acidic environment <strong>impairs the function of digestive enzymes </strong>(pancreatic enzymes), leading to the <strong>malabsorption of nutrients</strong>. This malabsorption results in an <strong>osmotic gradient</strong>, drawing water into the intestinal lumen, which contributes to <strong>diarrhea.</strong> </p>\n<p><strong>Treatment</strong> of individuals with Zollinger-Ellison syndrome includes blockade of acid hypersecretion, typically with <strong>proton pump inhibitors</strong>. </p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Other options:</strong></p>\n<p>Option A:<strong> VIPoma</strong> is characterized by watery diarrhea, hypokalemia, and achlorhydria (<strong>WDHA syndrome</strong>). It is caused by the release of vasoactive intestinal peptide (VIP) from the tumor.</p>\n<p>Option C:<strong> Glucagonomas</strong>, α-cell tumors are associated with increased serum levels of glucagon. The patient presents with mild diabetes mellitus, a characteristic skin rash (necrolytic migratory erythema), and anemia. They occur most frequently in perimenopausal and postmenopausal women and are characterized by extremely high plasma glucagon levels.</p>\n<p>Option D: <strong>Insulinomas</strong>, β-cell tumors are the most common pancreatic endocrine neoplasms. These are usually <strong>benign</strong> and often cause symptomatic hypoglycemia. Hypoglycemic symptoms appear when <strong>blood glucose </strong>levels fall<strong> below 50 mg/dL</strong>. The symptoms usually develop after fasting or exertion and improve after glucose intake.</p><hr><h3>Related Pearl: Pancreatic Endocrine Neoplasms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Endocrine neoplasm</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucagonoma</p>\n</td>\n<td>\n<p>Mild diabetes mellitus, a characteristic skin rash (necrolytic migratory erythema), and anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Insulinoma</p>\n</td>\n<td>\n<p>Clinically significant hypoglycemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gastrinoma</p>\n</td>\n<td>\n<p>Peptic ulceration often unresponsive to therapy and in unusual locations such as the jejunum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Somatostatinoma</p>\n</td>\n<td>\n<p>Diabetes mellitus, cholelithiasis, steatorrhea, and hypochlorhydria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VIPoma</p>\n</td>\n<td>\n<p>Watery diarrhea, hypokalemia, achlorhydria, or WDHA syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pancreatic polypeptide-secreting endocrine tumors</p>\n</td>\n<td>\n<p>Present as mass lesions as even high plasma levels of this hormone fail to cause symptoms</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Islet hyperplasia (previously known as nesidioblastosis) is seen in maternal diabetes, Beckwith&ndash;Wiedemann syndrome , and rare mutations in the &beta;-cell K+-channel protein or sulfonylurea receptor.</p>\n<p>In maternal diabetes, the fetal islets respond to hyperglycemia by increasing their size and number. In the postnatal period, these hyperactive islets may be responsible for serious episodes of hypoglycemia.</p><hr><h3>Related Pearl: Diagnostic tests in Zollinger Ellison Syndrome</h3><p>To confirm the diagnosis of ZES,</p>\n<ul>\n<li><strong>Gastric pH &lt;2.5</strong> and</li>\n<li><strong>Serum gastrin &gt;1000pg/ml</strong> (normal &lt;100pg/ml)</li>\n</ul>\n<p>Provocative tests can be done like the <strong>secretin stimulation test</strong> when the diagnosis is in doubt. An <strong>increase in serum gastrin &gt;200pg/ml</strong> following an IV bolus of secretin (2U/kg) is diagnostic.</p>\n<p>Other tests:</p>\n<ul>\n<li><strong>BAO &gt;15mEq/h</strong> (or &gt;5mEq/h if they have had a procedure for peptic ulcer)</li>\n<li><strong>BAO: MAO ratio </strong>is <strong>increased </strong>(<strong>&gt;0.6</strong>)</li>\n</ul>\n<p>(BAO=Basal acid output; MAO=Maximal acid output)</p>\n<p>For localization</p>\n<ul>\n<li>Initial investigation - CT or MRI</li>\n<li>Best investigation - <strong>Endoscopic ultrasound</strong></li>\n<li>If the tumor is not localized - <strong>Somatostatin receptor scintigraphy</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF7594",
      "difficulty": "easy"
    },
    {
      "text": "An infant was brought to the pediatrics department with poor sucking and difficulty in taking feed. He also had severe foul smelling greasy loose stools. A peripheral smear showed acanthocytosis. A biopsy specimen of the small intestine is shown below. Identify the underlying condition.",
      "choices": [
        {
          "id": 1,
          "text": "Lactase deficiency"
        },
        {
          "id": 2,
          "text": "Abetalipoproteinemia"
        },
        {
          "id": 3,
          "text": "Celiac disease"
        },
        {
          "id": 4,
          "text": "Whipple's disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical presentation of an<strong> infant</strong> presenting with&nbsp;<strong>failure to thrive</strong>, <strong>steatorrhea</strong>,<strong> acanthocytosis</strong> in the peripheral smear, and a histopathological image showing <strong>lipid-laden vacuolated epithelium</strong>&nbsp;is suggestive of <strong>abetalipoproteinemia</strong>.</p>\n<p>Abetalipoproteinemia is a rare&nbsp;<strong>autosomal recessive</strong> disease. It is caused due to the <strong>mutation</strong> in microsomal triglyceride transfer protein which leads to the inability to assemble triglyceride-rich lipoproteins. Thus <strong>lipids</strong> get <strong>accumulate</strong> intracellularly. It is predominantly seen in<strong> children</strong> during their <strong>first year of life</strong>. They present with failure to thrive and steatorrhea.</p>\n<p>Deep tendon reflexes are absent due to peripheral neuropathy and peripheral smear shows <strong>acanthocytosis</strong> due to lipid membrane defects, which is secondary to marked&nbsp;<strong>vitamin E deficiency</strong>.</p>\n<p>Histopathology shows&nbsp;<strong>normal intestinal mucosa</strong>&nbsp;except <strong>lipid-laden vacuolated epithelium</strong> due to triglyceride accumulation.&nbsp;Accumulated lipids disappear after infants stop taking feed.</p>\n<p>Low fat, high caloric, vitamin-enriched diet, and vitamin E in large doses should be given. Inadequate supply of vitamin E results in <strong>neurological degeneration</strong> and the development of <strong>retinitis pigmentosa</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60ffdd80c7fc4a239628d5825d0af8cdx1280x1573.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Diarrhea</strong> is defined as an increase in stool mass, frequency, or fluidity, typically greater than 200 gm per day. It can be classified into 4 types:</p>\n<ul>\n<li><strong>Secretory diarrhea</strong> is an isotonic stool and persists during fasting.</li>\n<li><strong>Osmotic diarrhea</strong> is due to the osmotic force exerted by unabsorbed luminal solutes. The diarrheal fluid is greater than 50 mOsm. Diarrhea decreases on fasting.</li>\n<li><strong>Malabsorptive diarrhea</strong> is due to failure of nutrient absorption. It is associated with steatorrhea and it gets relived on fasting.</li>\n<li><strong>Exudative diarrhea</strong> is due to inflammatory diseases which has pus and blood on them, it continues during fasting.</li>\n</ul>\n<p>Other options:</p>\n<p>Option A- <strong>Lactase deficiency&nbsp;</strong>is due to the <strong>absence</strong> of lactase in the villous epithelial cells. Lactose remains in the intestinal lumen and exerts an osmotic force causing <strong>osmotic diarrhea</strong>. Since the defect is biochemical, histology appears normal.</p>\n<p>Option C- <strong>Celiac disease</strong> is an immune-mediated disorder triggered by <strong>gluten-</strong>containing&nbsp;foods. Histology shows <strong>villous atrophy</strong> intraepithelial lymphocytosis and<strong> crypt hyperplasia</strong>. Plasma cells, mast cells, and eosinophils are seen in lamina propria.</p>\n<p>Histopathology image of celiac disease is shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e350973fe940450396ab932bb0a4f99dx800x533.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option D- <strong>Whipple's disease</strong> is a malabsorptive syndrome. Histology shows foamy macrophages in the small intestinal propria. The macrophages are laden with gram-positive, <strong>periodic acid-Schiff</strong> (PAS) positive, diastase resistant granules that have partially digested&nbsp;<strong><em>Tropheryma whipplei&nbsp;</em></strong>within the lysosome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f6796907615746a0b75f5d889d524d6cx1280x1574.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/53812b29d0554b23991e31b93dd2a985.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1915",
      "difficulty": "medium"
    },
    {
      "text": "A 44-year-old male patient with Crohn's disease underwent resection of a segment of the bowel. Following resection, the patient noticed that his stools have become bulky, pale, foul-smelling, and float in the toilet bowl. Which of the following statements is false regarding the resected segment of the bowel?",
      "choices": [
        {
          "id": 1,
          "text": "It is the only site of absorption of bile salts"
        },
        {
          "id": 2,
          "text": "It is the only site of absorption of vitamin B12"
        },
        {
          "id": 3,
          "text": "Resection of this segment leads to decreased gastric motility"
        },
        {
          "id": 4,
          "text": "Oral cholestyramine may be required in resections as small as 100cm"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The history of&nbsp;<strong>bulky, pale, and floating stools </strong>indicates<strong>&nbsp;steatorrhea </strong>which is seen in<strong> ileal resection.&nbsp;</strong>Resection of the ileum does not lead to decreased gastric motility.</p>\n<p>Small bowel <strong>motility</strong> is three times <strong>slower in</strong> the <strong>ileum</strong> than in the jejunum. In addition, the <strong>ileocaecal valve</strong> may <strong>slow</strong> the <strong>transit</strong>. Resection of the ileum, thus, results in a significant <strong>enhancement </strong>of<strong> gastric motility and</strong> acceleration of <strong>intestinal transit</strong>. This&nbsp;<strong>results in</strong> <strong>increased</strong> delivery of <strong>fluids and electrolytes</strong> to the <strong>colon</strong> which results in symptoms of<strong> diarrhea</strong>.&nbsp;</p>\n<p>The <strong>ileum</strong> is the <strong>only</strong> <strong>site</strong> of <strong>absorption</strong> of <strong>vitamin B<sub>12</sub></strong> and <strong>bile salts </strong>(Options A &amp; B). <strong>Following resection</strong> of the ileum, the <strong>loss of bile salts increases</strong> and is not met by an increase in synthesis. Depletion of the bile salt pool <strong>results in</strong> fat malabsorption (<strong>steatorrhea</strong>).&nbsp;The loss of<strong> bile salts into</strong> the <strong>colon</strong> affects the colonic mucosa, causing a<strong> reduction</strong> in <strong>salt and water absorption</strong>, which increases stool losses.&nbsp;</p>\n<p>Resections as small as 100cm can cause steatorrhoea, which<strong> requires</strong> the administration of <strong>oral cholestyramine to bind</strong> the<strong> bile salts </strong>(Option D). <strong>Larger resections</strong> may <strong>require dietary fat restriction</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5943d19b9074d70b9551d54fe3e3846x1200x1616.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0034",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following alpha beta 7 integrin inhibitors is used in the treatment of Crohn's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Certolizumab"
        },
        {
          "id": 2,
          "text": "Adalimumab"
        },
        {
          "id": 3,
          "text": "Natalizumab"
        },
        {
          "id": 4,
          "text": "Vedolizumab"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Vedolizumab</strong> is a humanized <strong>anti-alpha-4-beta-7 integrin</strong> <strong>monoclonal antibody</strong> that <strong>prevents lymphocyte</strong> recruitment to the intestinal mucosa and is approved for use in moderate-severe <strong>Crohn's</strong> disease and <strong>ulcerative</strong> colitis.</p>\n<p><strong>Anti-TNF alpha</strong> monoclonal antibodies indicated in IBD are: </p>\n<ul>\n<li>Infliximab</li>\n<li><strong>Adalimumab</strong></li>\n<li><strong>Certolizumab</strong> pegol</li>\n</ul>\n<p>Other options : </p>\n<p>Option C: <strong>Natalizumab</strong> is an <strong>anti-alpha-4-beta-7 integrin</strong> inhibitor <strong>monoclonal antibody</strong> used in treating <strong>Multiple Sclerosis</strong>, particularly in patients who are JC virus negative.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0534",
      "difficulty": "hard"
    },
    {
      "text": "A patient with celiac disease presents with peripheral neuropathy and decreased vibration and position sense. Investigations show hemolytic anemia and normal methylmalonic acid levels. Which of the following is most likely deficient in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Pyridoxine"
        },
        {
          "id": 2,
          "text": "Folate"
        },
        {
          "id": 3,
          "text": "Vitamin B12"
        },
        {
          "id": 4,
          "text": "Vitamin E"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This patient has <strong>chronic malabsorption</strong> due to <strong>celiac disease</strong>, and has now presented with <strong>peripheral neuropathy</strong> and <strong>posterior column involvement</strong> (loss of vibration and position sense). The presence of <strong>hemolytic anemia</strong> along with these features points to a diagnosis of <strong>vitamin E deficiency</strong>.</p>\n<p><strong>Vitamin E (&alpha;-tocopherol)</strong> acts as an <strong>antioxidant</strong> by scavenging free radicles. It is a <strong>fat-soluble vitamin</strong>, and so the <strong>deficiency</strong> is only seen <strong>in</strong> patients with <strong>prolonged malabsorption</strong>, such as <strong>celiac disease</strong> and <strong>chronic cholestatic liver disease</strong>. Children with <strong>abetalipoproteinemia</strong> cannot absorb vitamin E and also show symptoms of deficiency.&nbsp;</p>\n<p><strong>Deficiency</strong> of vitamin E <strong>causes</strong> <strong>axonal degeneration of myelinated neurons</strong>, causing <strong>posterior column</strong> and <strong>spinocerebellar involvement</strong>. Patients can have <strong>peripheral neuropathy</strong>, <strong>ataxia</strong>, and <strong>loss of vibration </strong>and<strong> position sense</strong>. Along with this, there is <strong>hemolytic anemia&nbsp;</strong>because of unchecked lipid peroxidation of the RBC membrane in the absence of the antioxidant effects of vitamin E.</p>\n<p>Vitamin B12 deficiency (option C) can also present with involvement of the posterior column, but the following features differentiate it from vitamin E deficiency:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Vitamin E deficiency</strong></td>\n<td><strong>Vitamin B12 deficiency</strong></td>\n</tr>\n<tr>\n<td>Anemia</td>\n<td>Hemolytic anemia</td>\n<td>Megaloblastic anemia</td>\n</tr>\n<tr>\n<td>Peripheral smear</td>\n<td>Acanthocytes</td>\n<td>Macroovalocytes with hypersegmented neutrophils</td>\n</tr>\n<tr>\n<td>Serum methylmalonic acid levels</td>\n<td>Normal</td>\n<td>Elevated</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Other options:</p>\n<p>Option A: <strong>Pyridoxine</strong> <strong>deficiency</strong> presents with <strong>epithelial changes</strong> such as cheilitis, along with <strong>peripheral neuropathy</strong>,&nbsp;personality changes, and depression. There is <strong>no involvement of</strong> the <strong>posterior column</strong> tracts. Pyridoxine deficiency can cause <strong>microcytic hypochromic anemia </strong>due to diminished hemoglobin synthesis, since the aminolevulinate synthase enzyme in heme synthesis is PLP dependent.&nbsp;</p>\n<p>Option B: <strong>Folate deficiency </strong>presents with <strong>megaloblastic anemia</strong> <strong>without neurological symptoms</strong>. There is an <strong>elevation of serum homocysteine</strong> levels but <strong>methylmalonic acid levels</strong> are <strong>normal</strong>, versus vitamin B12 deficiency, where both are elevated.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9929",
      "difficulty": "hard"
    },
    {
      "text": "A 35-year-old gentleman presents to the clinic with bloody diarrhea, tenesmus, and crampy abdominal pain for the past week. The colonoscopy image is given below. Which of the following is commonly not associated with the patient's condition?",
      "choices": [
        {
          "id": 1,
          "text": "Arthritis"
        },
        {
          "id": 2,
          "text": "Urethritis"
        },
        {
          "id": 3,
          "text": "Iritis"
        },
        {
          "id": 4,
          "text": "Pyoderma gangrenosum"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario and the endoscopic image point to a diagnosis of&nbsp;<strong>ulcerative colitis</strong>.<strong> Urethritis</strong> is <strong>not</strong> an&nbsp;extraintestinal manifestation of ulcerative colitis.</p>\n<p>Ulcerative colitis is characterized by recurring episodes of inflammation limited to the mucosa of the colon and rectum. It presents with chronic diarrhea, <strong>tenesmus,</strong> mucus and blood passage per rectum, and crampy abdominal pain.</p>\n<p><strong>Sigmoidoscopy</strong> shows severe colon inflammation with erythema, friability, and exudates. Active disease is associated with a rise in acute-phase reactants (C-reactive protein), platelet count, erythrocyte sedimentation rate (ESR), and a decrease in hemoglobin.&nbsp;Diagnosis is based on the patient&rsquo;s clinical symptoms, sigmoidoscopic appearance, and histology of rectal or colonic biopsy specimens.</p>\n<p><strong>Extraintestinal manifestations of ulcerative colitis&nbsp;</strong></p>\n<ul>\n<li>Musculoskeletal -\n<ul>\n<li><strong>Arthritis</strong></li>\n<li>Sacroiliitis</li>\n<li>Ankylosing spondylitis</li>\n</ul>\n</li>\n<li>Eye -<br />\n<ul>\n<li><strong>Uveitis/Iritis</strong></li>\n<li>Episcleritis</li>\n</ul>\n</li>\n<li>&nbsp;Skin -\n<ul>\n<li>Erythema nodosum</li>\n<li><strong>Pyoderma gangrenosum</strong></li>\n</ul>\n</li>\n<li>Hepatobiliary -\n<ul>\n<li><strong>Primary sclerosing cholangitis</strong></li>\n<li>Fatty liver</li>\n<li>Cholelithiasis</li>\n</ul>\n</li>\n<li>Hematopoietic/coagulation -\n<ul>\n<li>Venous and arterial thromboembolism</li>\n</ul>\n</li>\n<li>Cardiopulmonary -<br />\n<ul>\n<li>Interstitial lung disease</li>\n<li>pleuropericarditis</li>\n<li>endocarditis</li>\n<li>myocarditis</li>\n</ul>\n</li>\n<li>Urologic -\n<ul>\n<li>Calculi</li>\n<li>Ureteral obstruction</li>\n<li>Ileal bladder fistula</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Inflammatory Bowel Disease (IBD)</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset </strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades </td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td> None </td>\n<td>\n<p>Smoking </p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life </p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1 </td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement </p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps </p>\n<p>Backwash ileitis </p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings </strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia  </p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications </strong></td>\n<td>\n<p>Fistulas </p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings </strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis </p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b8e331355f5941a28cf3440c4df8af64.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5039",
      "difficulty": "medium"
    },
    {
      "text": "An obese patient was prescribed a drug for weight loss that acts by inhibiting gastrointestinal lipase. Which among the following is the prescribed drug?",
      "choices": [
        {
          "id": 1,
          "text": "Liraglutide"
        },
        {
          "id": 2,
          "text": "Orlistat"
        },
        {
          "id": 3,
          "text": "Phentermine"
        },
        {
          "id": 4,
          "text": "Ezetimibe"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Orlistat</strong> is a drug indicated for <strong>weight loss</strong> and acts by <strong>inhibiting gastrointestinal lipase</strong> resulting in <strong>reduced lipid absorption</strong>.</p>\n<p><strong>Orlistat</strong> is a <strong>reversible gastrointestinal lipase inhibitor</strong> required for the hydrolysis of dietary fat into fatty acids and monoacylglycerols. Orlistat acts in the lumen of stomach and small intestine by forming covalent bonds with the active site of lipases. This leads to <strong>reduced digestion and absorption</strong> <strong>of dietary fat</strong>. <strong>Adverse effects</strong> include <strong>flatus with discharge, fecal urgency, fatty/oily stool</strong>, and <strong>increased defecation</strong>. These side effects are experienced early and <strong>diminish</strong> as patients <strong>control their dietary fat intake</strong>. <strong>Vitamin supplements</strong> are indicated to prevent fat soluble vitamin deficiency.<br /><br /><strong>Adjuvant pharmacologic treatments</strong> for <strong>obesity</strong> should be considered for patients with a <strong>BMI ≥30 kg/m2</strong>, or for patients with a <strong>BMI ≥27 kg/m2 </strong>who have <strong>concomitant obesity-related diseases</strong> and for whom <strong>dietary and physical activity therapy</strong> has <strong>not been successful</strong>. Medications for obesity include those that affect <strong>appetite</strong> (liraglutide, phentermine)  and those that <strong>inhibit gastrointestinal fat absorption</strong> (orlistat).</p>\n<p>Other options:</p>\n<p>Option A: <strong>Liraglutide</strong> is a <strong>glucagon-like peptide-1 (GLP-1)</strong> <strong>analogue</strong> which is approved for the treatment of <strong>type 2 diabetes</strong>, and is used as an off label indication for <strong>weight loss</strong>. It acts as an <strong>incretin hormone</strong> (glucose-induced insulin secretion), <strong>inhibits both gastric emptying</strong> and <strong>glucagon</strong> <strong>secretion</strong> and stimulates GLP-1 receptors in the arcuate nucleus of hypothalamus to <strong>reduce feeding</strong>.</p>\n<p>Option C: <strong>Phentermine</strong> is a <strong>sympathomimetic central appetite suppressant</strong> medication that acts by increasing central norepinephrine release.</p>\n<p>Option D: <strong>Ezetimibe</strong> selectively <strong>inhibits intestinal absorption of cholesterol</strong> and phytosterols, and is used in the management of <strong>hypercholesterolemia</strong>. It is not indicated in the treatment of obesity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG1484",
      "difficulty": "medium"
    },
    {
      "text": "A 12-year-old boy presented with complaints of weight loss, malaise, and passing loose, bulky stools for the past 4 months. Stools were initially profuse and watery and later became greasy and foul-smelling, often associated with abdominal pain. A wet preparation of the stool sample is shown in the image below. All of the following drugs are used to treat this condition, except:",
      "choices": [
        {
          "id": 1,
          "text": "Tinidazole"
        },
        {
          "id": 2,
          "text": "Nitazoxanide"
        },
        {
          "id": 3,
          "text": "Metronidazole"
        },
        {
          "id": 4,
          "text": "Albendazole"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical vignette showing the child having loose<strong> greasy stools</strong> and pain abdomen along with the image showing <strong>cysts of Giardia lamblia</strong> is strongly suggestive of <strong>Giardiasis. </strong>For this condition, Metronidazole/tinidazole/Nitazoxanide are the first-line agents while Albendazole is not used in treatment. </p>\n<p>Infection occurs by the <strong>ingestion of cysts</strong> in contaminated water, food, or by the fecal-oral route (hands or fomites). The incubation period is usually about<strong> 2 weeks. </strong>Cysts are the infective form of the parasite. Cysts are resistant forms and are responsible for the transmission of giardiasis. Both cysts and trophozoites can be found in the faeces (diagnostic stages). The cysts are hard and can survive up to 3 months in cold water.</p>\n<p>In the<strong> small intestine,</strong> excystation releases trophozoites (each cyst produces two trophozoites). It is the <strong>only </strong>common pathogenic<strong> protozoan</strong> in the human intestines, adhering to the duodenal or upper jejunal mucosa by a ventral sucking disk.</p>\n<p>Clinical features:</p>\n<ul>\n<li>Diarrhea, fat malabsorption, dull epigastric pain, belching, and flatulence. The stool contains excess mucus and fat but no blood.</li>\n<li>Abnormal stool patterns may alternate with periods of constipation and normal bowel movements.</li>\n<li>It is associated with iron deficiency and growth stunting</li>\n</ul>\n<p>Diagnosis:-</p>\n<ul>\n<li>Wet mount preparation of stool samples for microscopy to identify cysts and trophozoites during the active stage of the disease.</li>\n<li>The String test/Entero test is used. It is a useful method for obtaining the duodenal specimen in giardiasis.</li>\n<li>Sero diagnosis: Commercially available ELISA kits detect Giardia-specific antigen ( GSA 65 ). <strong>ELISA </strong>kits (ProSpecT/ Giardia kit) detect Giardia-specific antigen 65 (GSA 65)<strong> </strong>and have a<strong> sensitivity of 95% </strong>and<strong> specificity of 100%, </strong>compared to conventional microscopy.</li>\n</ul>\n<p>Treatment: <strong>Metronidazole/tinidazole/nitazoxanide</strong> are the first-line agents.</p>\n<p>Other options :</p>\n<p><strong>Entamoeba histolytica</strong> causes <strong>amoebic dysentery</strong> which can be acute intestinal amebiasis presenting with dysentery, lower abdominal discomfort, and flatulence, or chronic amebiasis which presents with low-grade symptoms such as occasional diarrhoea, weight loss, and fatigue. Fat malabsorption is not commonly seen.</p>\n<p><strong>Balantidium coli</strong> is the <strong>only ciliated protozoa</strong> and it is present in the <strong>large intestine as a commensal.</strong> It is also the largest protozoan parasite of humans. Living trophozoites/cysts are yellowish or greenish on wet mount which can be easily differentiated from Giardia lamblia. </p><hr><h3>Related Pearl: Infective form and diagnostic forms of various protozoa</h3><table dir=\"ltr\"><colgroup><col /><col /><col /></colgroup>\n<tbody>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Parasite&quot;}\"><strong>Parasite</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Infective form&quot;}\"><strong>Infective form</strong></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Diagnostic form&quot;}\"><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Entamoeba histolytica&quot;}\"><em>Entamoeba histolytica</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Mature quadrinucleate cyst&quot;}\">Mature quadrinucleate cyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites, quadrinucleate cyst&quot;}\">Trophozoites, quadrinucleate cyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Giardia lamblia&quot;}\"><em>Giardia lamblia</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Quadrinucleate cyst&quot;}\">Quadrinucleate cyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites, cyst&quot;}\">Trophozoites, cyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trichomonas vaginalis&quot;}\"><em>Trichomonas vaginalis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites&quot;}\">Trophozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites&quot;}\">Trophozoites</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Naegleria fowleri&quot;}\"><em>Naegleria fowleri</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite&quot;}\">Trophozoite</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite in CSF&quot;}\">Trophozoite in CSF</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Acanthamoeba&quot;}\"><em>Acanthamoeba</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoites and cysts&quot;}\">Trophozoites and cysts</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trophozoite in CSF&quot;}\">Trophozoite in CSF</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Leishmania donovani &quot;}\"><em>Leishmania donovani</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Promastigote&quot;}\">Promastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;amastigotes in macrophage&quot;}\">amastigotes in macrophage</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypanosoma cruzi&quot;}\"><em>Trypanosoma cruzi</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Metacyclic Trypomastigote&quot;}\">Metacyclic Trypomastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypomastigote&quot;}\">Trypomastigote</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypanosoma brucei&quot;}\"><em>Trypanosoma brucei</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Metacyclic Trypomastigote&quot;}\">Metacyclic Trypomastigote</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Trypomastigote&quot;}\">Trypomastigote</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Balantidium coli&quot;}\"><em>Balantidium coli</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysts&quot;}\">Cysts</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cysts&quot;}\">Cysts</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Plasmodium&quot;}\"><em>Plasmodium </em>spp.</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporozoites&quot;}\">Sporozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Schizont, immature trophozoite, mature trophozoite, gametocyte&quot;}\">Schizont, immature trophozoite, mature trophozoite, gametocyte</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Babesia&quot;}\"><em>Babesia </em>spp.</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporozoites&quot;}\">Sporozoites</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Maltese cross form&quot;}\">Maltese cross form</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Toxoplasma gondii&quot;}\"><em>Toxoplasma gondii</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;All 3 morphological forms - oocyst, tachyzoite, bradyzoite&quot;}\">All 3 morphological forms - oocyst, tachyzoite, bradyzoite</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Tissue cysts&quot;}\">Tachyzoites, tissue cysts</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cryptosporidium&quot;}\"><em>Cryptosporidium parvum</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Cyclospora&quot;}\"><em>Cyclospora cayetanensis</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;unsporulated oocyst&quot;}\">unsporulated oocyst</td>\n</tr>\n<tr>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Isospora&quot;}\"><em>Isospora belli</em></td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sporulated oocyst&quot;}\">Sporulated oocyst</td>\n<td data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;unsporulated oocyst&quot;}\">unsporulated oocyst</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/248e5be188164bcba60771a2b6cc8f7a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3370",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old female patient comes with a history of chronic weight loss, loss of appetite, and diarrhea along with pale bulky stools and is diagnosed with malabsorption syndrome. Steatorrhea is defined in this patient by stool fat exceeding:",
      "choices": [
        {
          "id": 1,
          "text": "7 g per day"
        },
        {
          "id": 2,
          "text": "14 g per day"
        },
        {
          "id": 3,
          "text": "28 g per day"
        },
        {
          "id": 4,
          "text": "32 g per day"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Steatorrhea is a symptom&nbsp;defined by stool fat exceeding <strong>7 g per day.</strong></p>\n<p>Steatorrhea is the passage of <strong>greasy, foul-smelling, difficult-to-flush</strong> stools.&nbsp;It is often associated with weight loss &amp; nutritional deficiencies due to concomitant malabsorption of amino acids &amp; fat-soluble vitamins. It is one of the clinical features of <strong>fat malabsorption</strong> and is noted in many conditions causing intraluminal maldigestion, mucosal malabsorption, or lymphatic obstruction.</p>\n<p>Causes of steatorrhea:</p>\n<ul>\n<li class=\"half_rhythm\">\n<div>Exocrine <strong>pancreatic insufficiency</strong>: Chronic pancreatitis, cystic fibrosis (CF), pancreatic tumors</div>\n</li>\n<li class=\"half_rhythm\">\n<div><strong>Bile acid deficiency</strong>: Primary biliary cholangitis&nbsp;(PBC), primary sclerosing cholangitis (PSC), ileal resection, Crohn disease, small&nbsp;intestinal bacterial overgrowth (SIBO)</div>\n</li>\n<li class=\"half_rhythm\">\n<div><strong>Enteropathy </strong>or<strong>&nbsp;</strong>Malabsorption syndrome: Celiac disease (most common), tropical sprue, giardiasis, Whipple disease, amyloidosis, SIBO, abetalipoproteinemia</div>\n</li>\n</ul>\n<p>Screening of steatorrhea is by the detection of fat&nbsp;by <strong>Sudan III staining. </strong>Stool fat can be quantified&nbsp;by calculating the coefficient of fat absorption <strong>(CFA), </strong>which is an essential step in the diagnosis.</p><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2862",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man presented to the OPD with complaints of fever, epigastric discomfort, progressive weight loss, and foul-smelling diarrhea for the past 6 months. He recently also developed severe pain in his right knee. A malabsorption syndrome is suspected and a biopsy is taken which shows the following picture. A disturbance in which phase of nutrient absorption is seen in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Lymphatic transport"
        },
        {
          "id": 2,
          "text": "Terminal digestion"
        },
        {
          "id": 3,
          "text": "Intraluminal digestion"
        },
        {
          "id": 4,
          "text": "Transepithelial transport"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette showing foul-smelling diarrhea, weight loss, arthralgia, and histopathology showing dense accumulation of <strong>distended, foamy macrophages in the small intestinal lamina propria </strong>and macrophages containing<strong> periodic acid–Schiff (PAS)-positive, diastase-resistant granules</strong> is suggestive of <strong>Whipple disease</strong> where there is a disturbance in the <strong>lymphatic transport</strong> of absorbed lipids.</p>\n<p>Whipple's disease is a chronic multisystem disorder caused by the gram-positive bacteria Tropheryma whipplei. It presents as diarrhea, steatorrhea, weight loss, arthralgia, and central nervous system &amp; cardiac problems. The morphologic hallmark of Whipple disease is a dense accumulation of <strong>distended, foamy macrophages in the small intestinal lamina propria</strong>. Macrophages contain<strong> periodic acid–Schiff (PAS)-positive, diastase-resistant granules</strong> that represent lysosomes stuffed with partially digested bacteria.</p>\n<p><strong>Steatorrhea</strong> is characterized by excessive fecal fat and bulky, frothy, greasy, yellow, or clay-colored stools. Chronic malabsorptive disorders commonly occur due to pancreatic insufficiency, celiac disease, and Crohn's disease. In Whipple disease, the cause of malabsorption is<strong> impaired lymphatic transport. </strong>In Whipple disease, clinical symptoms occur because organism-laden macrophages accumulate within the small intestinal lamina propria and mesenteric lymph nodes, causing lymphatic obstruction.</p>\n<p><strong>Malabsorption</strong> occurs due to disturbance in at least one of the<strong> four phases of nutrient absorption:</strong></p>\n<ul>\n<li><strong>Intraluminal digestion:</strong> In this phase, the proteins, carbohydrates, and fats are broken down into suitable forms for absorption. Diseases with abnormalities in this phase include <strong>chronic pancreatitis</strong> and <strong>cystic fibrosis</strong>.</li>\n<li><strong>Terminal digestion:</strong> This phase involves hydrolysis of carbohydrates and peptides by the enzymes in the brush border of the small intestinal mucosa. Diseases with abnormalities in this phase include <strong>celiac disease, inflammatory bowel disease</strong>.</li>\n<li><strong>Transepithelial transport: </strong>In this phase nutrients, fluid, and electrolytes are transported across the small intestinal epithelium, and are processed within the epithelium as they pass. Diseases with abnormalities in this phase include <strong>cystic fibrosis, celiac disease, and inflammatory bowel disease</strong>.</li>\n<li><strong>Lymphatic transport: </strong>The absorbed lipids are transported. Abnormality in this phase is seen in <strong>Whipple disease</strong>.</li>\n</ul><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/124d7894e36d44a987864dfa1e55d8b7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0166",
      "difficulty": "hard"
    },
    {
      "text": "A middle-aged woman is suffering from diarrhea, floating stools, and weight loss for the past 3 months. An intestinal biopsy is provided below showing partial villous atrophy and marked intraepithelial lymphocytosis. Her symptoms do not improve after eliminating gluten from the diet. Which treatment should be administered?",
      "choices": [
        {
          "id": 1,
          "text": "Tetracycline + Vitamin B12"
        },
        {
          "id": 2,
          "text": "Metronidazole + Folic acid"
        },
        {
          "id": 3,
          "text": "Tetracycline + Folic acid"
        },
        {
          "id": 4,
          "text": "Amoxicillin + Vitamin B12"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario of a woman presenting with <strong>diarrhoea, floating stools and weight loss</strong> for 3 months with given histopathology indicating <strong>inflammation of lamina propria</strong> and<strong> no improvement with a gluten-free diet </strong>is suggestive of <strong>tropical sprue. </strong>The treatment of tropical sprue is <strong>tetracycline + folic acid</strong>. Because of marked folate deficiency, folic acid is most often given together with broad-spectrum antibiotics for <strong>up to 6 months.</strong> </p>\n<p><strong>Tropical sprue</strong> is an acquired malabsorptive condition of probable <strong>infectious </strong>aetiology. Patients present with <strong>diarrhoea, steatorrhoea, weight loss</strong>, <strong>folic acid,</strong> and <strong>vitamin B12 deficiency.</strong></p>\n<p>The small intestinal mucosal biopsy is <strong>diagnostic</strong> and reveals partial villous atrophy and mononuclear cell infiltration in the lamina propria. </p><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/558934b3f28849c4b44f7d90aabbf728.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6635",
      "difficulty": "medium"
    },
    {
      "text": "A 12-year-old girl has had a history of recurrent bulky stools and abdominal pain since 3 years of age. She has pallor, and her weight and height are below the 3rd percentile. Which of the following is the most appropriate investigation to make a specific diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Small intestinal biopsy"
        },
        {
          "id": 2,
          "text": "Barium studies"
        },
        {
          "id": 3,
          "text": "24-hour fecal fat estimation"
        },
        {
          "id": 4,
          "text": "Urinary D-xylose test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>A small intestinal biopsy</strong> can help diagnose <strong>documented steatorrhea or chronic diarrhea (&gt;3 weeks).</strong> Failure to thrive in the setting of recurrent bulky stools and abdominal pain suggests a diagnosis of <strong>chronic malabsorption.</strong></p>\n<p>Endoscopy is the preferred method of obtaining histologic material from the proximal small-intestinal mucosa.</p>\n<p>The other options are not specific tests used to confirm malabsorption syndromes.</p>\n<p>Lesions seen on small-bowel biopsy can be classified into three categories according to their distribution and specificity of findings; diseases in which these lessons are seen and the associated pathologic findings are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Lesions</strong></td>\n<td><strong>Pathologic Findings</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Diffuse, Specific</strong> </td>\n</tr>\n<tr>\n<td>Whipple disease</td>\n<td>Lamina propria includes macrophages containing material positive on periodic acid–Schiff staining</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Patchy, Specific</strong> </td>\n</tr>\n<tr>\n<td>Crohn disease</td>\n<td>Noncaseating granulomas</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Diffuse, Nonspecific</strong> </td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>Short or absent vill, mononuclear infiltrate, epithelial cell damage,  hypertrophy of crypts</td>\n</tr>\n<tr>\n<td>Folate deficiency</td>\n<td>Short villi, decreased mitosis in crypts, megalocytosis</td>\n</tr>\n<tr>\n<td>Zollinger-Ellison syndrome  </td>\n<td>Mucosal ulceration and erosion from acid</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Investigations in  Malabsorption Syndrome</h3><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipple's disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6473",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following tests helps to distinguish inflammatory bowel disease from irritable bowel syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Fecal calprotectin"
        },
        {
          "id": 2,
          "text": "Serum albumin"
        },
        {
          "id": 3,
          "text": "C - reactive protein"
        },
        {
          "id": 4,
          "text": "Erythrocyte sedimentation rate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Assessment of <strong>fecal calprotectin</strong> levels helps to distinguish inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS).</p>\n<p>The <strong>fecal calprotectin</strong> and <strong>lactoferrin</strong> are elevated in <strong>inflammatory conditions</strong> like inflammatory bowel disease, but not in irritable bowel syndrome. Hence, they are often assessed to distinguish the two conditions. These tests are also done to check if the disease is active and to detect postoperative recurrence. Other features of IBD include <strong>elevated</strong> <strong>erythrocyte sedimentation rate</strong> (ESR) and <strong>C-reactive protein</strong> (CRP), <strong>hypoalbuminemia</strong>, anemia, and leukocytosis.</p>\n<div class=\"page\" title=\"Page 9094\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Irritable bowel syndrome (IBS) is a <strong>functional disorder</strong> characterized by abdominal pain or discomfort and altered bowel habits in the <strong>absence of structural abnormalities</strong>. There are <strong>no clear diagnostic markers</strong> for IBS. The presence of anemia, elevated ESR, leukocytosis, bloody stool, or stool volume of more than 200 - 300 ml/day argues <strong>against</strong> the diagnosis of IBS. The diagnosis is mainly based on clinical presentation.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: ROME IV Diagnostic criteria for IBS</h3><p class=\"bulletIndent1\">According to the Rome IV criteria, IBS is defined as recurrent <strong>abdominal pain </strong>for&nbsp;at least <strong>1 day per week</strong> in the last <strong>3 months</strong>. It must be associated with <strong>2 or more</strong> of the following criteria:</p>\n<ul>\n<li class=\"bulletIndent2\">Related to defecation&nbsp;(improvement or worsening)</li>\n<li class=\"bulletIndent2\">Associated with a change in stool frequency</li>\n<li class=\"bulletIndent2\">Associated with a change in stool form (appearance)</li>\n</ul>\n<p>The above criteria must be fulfilled for <strong>3 months</strong> with&nbsp;<strong>onset</strong>&nbsp;of some symptoms at least <strong>6 months</strong> before diagnosis.</p><hr><h3>Related Pearl: Drugs used in irritable bowel syndrome (IBS)</h3><p>For abdominal pain</p>\n<ul>\n<li>Antispasmodics - Dicyclomine</li>\n<li>Tricyclic antidepressants - Amitriptyline, Imipramine</li>\n<li>Selective serotonin reuptake inhibitor - Citalopram</li>\n</ul>\n<p>For diarrhoea</p>\n<ul>\n<li>Opiate - Loperamide</li>\n<li>5-HT3 antagonist - Alosetron</li>\n<li>Bile acid sequestrant - Cholestyramine resin</li>\n</ul>\n<p>For constipation</p>\n<ul>\n<li>Laxatives such as psyllium/ispaghula husk and polyethylene glycol</li>\n<li>Cl<sup>-</sup> channel activator - Lubiprostone</li>\n<li>Guanylate cyclase agonist - Linaclotide</li>\n<li>5-HT4 agonist - Tegaserod</li>\n<li>Selective serotonin reuptake inhibitor - Paroxetine</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0890",
      "difficulty": "easy"
    },
    {
      "text": "A 34-year-old male patient presented to the clinic with a history of diarrhoea and poor appetite. He has been having 4-5 episodes of non-bloody, loose stools per day for the last 3 months. A duodenal biopsy is taken and the histopathology is shown below. Which of the following statements is false about this given condition?",
      "choices": [
        {
          "id": 1,
          "text": "MARSH score is used for diagnosis of this condition"
        },
        {
          "id": 2,
          "text": "Increased association with dermatitis herpetiformis"
        },
        {
          "id": 3,
          "text": "Histopathological study reveals raised intraepithelial macrophages"
        },
        {
          "id": 4,
          "text": "Anti-endomysial antibodies are associated with this condition"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario of diarrhoea and poor appetite and histopathology findings (explained below) are suggestive of <strong>celiac disease</strong>. Histopathological study reveals <strong>raised</strong> <strong>intraepithelial</strong> <strong>lymphocytes. </strong>Hence, Option C is a false statement.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a7edd0b4a5014729be77edb0f15b1779x1280x1230.JPEG\" alt=\"Explanation Image\"><p>Celiac disease or celiac sprue or gluten-sensitive enteropathy is triggered by the ingestion of <strong>gluten</strong>-containing foods such as barley, rye, oats, and wheat (mnemonic: BROW) in genetically predisposed individuals. It usually affects the <strong>2nd part</strong> of the <strong>duodenum</strong> or <strong>proximal jejunum.  triggered by the ingestion of gluten-containing foods such as barley, rye, oats, and wheat (mnemonic: BROW) in genetically predisposed individuals.</strong></p>\n<p>Diagnosis:</p>\n<ul>\n<li>The single best screening test for Celiac disease is Tissue Transglutaminase Ab (tTG-IgA) which has a sensitivity of about 98% &amp; specificity of about 95%.</li>\n<li><strong>Anti-gliadin antibodies </strong>are produced in response to gliadin, a component found in wheat. Antigliadin antibody tests (AGA-IgA and AGA-IgG) have lower diagnostic accuracy. <strong>Anti-tissue transglutaminase antibodies</strong> (anti-ttG) and <strong>Anti-endomysial antibodies</strong> (Option D) are other antibodies associated with celiac disease.</li>\n<li><strong>HLA-DQ2 or DQ8</strong> are present in most patients with celiac disease. HLA testing has a positive predictive value of 12 percent. Hence, HLA testing is useful only in ruling out celiac disease. </li>\n<li><strong>Endoscopy</strong> with <strong>small bowel biopsy</strong> is used as a <strong>confirmatory test</strong> to diagnose celiac disease and not as an initial test in suspected cases.</li>\n<li>The histopathology is characterized by <strong>villous atrophy</strong>, <strong>crypt hyperplasia</strong>, and <strong>increased intraepithelial CD8+T lymphocytes</strong>. An increase in the number of intraepithelial lymphocytes is a sensitive marker of celiac disease, even in the absence of epithelial damage and villous atrophy. MARSH's Score is used to assess celiac disease histologically. (Option A)</li>\n</ul>\n<p><strong>Dermatitis herpetiformis</strong> can occur in as many as 10% of patients. (Option B)</p>\n<p>The mainstay of treatment is a gluten-free diet. </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>Celiac Sprue</td>\n<td>Tropical Sprue</td>\n<td>Whipple's Disease</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Proximal small intestine</td>\n<td>Distal small intestine</td>\n<td>Proximal+ Distal small intestine</td>\n</tr>\n<tr>\n<td>Extraintestinal manifestation</td>\n<td>Present (most common is Dermatitis Herpetiformis)</td>\n<td>Absent</td>\n<td>Present (MC-Migratory polyarthritis, MC in CVS-Endocarditis, MC in CNS-Dementia)</td>\n</tr>\n<tr>\n<td>Antibodies (Antiendomysial and IgA Anti TTG)</td>\n<td>Positive</td>\n<td>Negative</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e2995477e6d34796b6802fa634f98511.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6654",
      "difficulty": "medium"
    },
    {
      "text": "A patient with Crohn's disease who underwent multiple sequential ileal resections and removal of his terminal ileum and proximal cecum presents with bloating, flatulence, and watery diarrhea. The lactulose breath test shows a higher-than-normal reading after 1 hour.  Which of the following is the cause of his symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Bile irritation to intestinal wall"
        },
        {
          "id": 2,
          "text": "Resection of the ileo cecal valve"
        },
        {
          "id": 3,
          "text": "Dumping syndrome"
        },
        {
          "id": 4,
          "text": "Increased colonic motility"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Multiple sequential ileal resections, typical of patients with <strong>Crohn’s disease</strong> can cause <strong>short bowel syndrome </strong>(<strong>&lt;150 cm </strong>of the<strong> residual small bowel). Flatulence</strong>, <strong>diarrhea</strong>, and a <strong>higher than normal</strong> concentration of <strong>Hydrogen</strong> on lactulose breath test make <strong>small intestinal bacterial overgrowth (SIBO)</strong> the most likely diagnosis. Resection of the <strong>ileocecal</strong> valve is the probable cause of his symptoms as it removes the barrier between the small and large bowel allowing for the colonic bacteria to colonise the small intestine. </p>\n<p>Massive intestinal resection (<strong>&lt;150 cm</strong> of the <strong>residual small bowel</strong>) results in metabolic and nutritional consequences, is known as <strong>short bowel syndrome</strong>.</p>\n<p>Complications of short bowel syndrome include:</p>\n<ul>\n<li><strong>Diarrhea</strong> (due to <strong>hypergastrinemia</strong> and <strong>gastric hypersecretion</strong>, SIBO or unabsorbed <strong>bile salts</strong> in the colon)</li>\n<li><strong>Steatorrhea</strong> (due to the depletion of the bile salt pool)</li>\n<li><strong>Gallstones</strong> (due to interruption of the enterohepatic cycle of bile salts)</li>\n<li><strong>Renal stones</strong> (due to <strong>increased</strong> absorption of <strong>oxalate</strong> in the colon).</li>\n</ul>\n<p>SIBO is a condition characterized by overgrowth of bacteria in the small bowel. this can lead to bloating, flatulence, and secretory diarrhea.</p>\n<p>Risk factors for SIBO:</p>\n<ul>\n<li>Surgically created blind loops</li>\n<li><strong>Short bowel syndrome</strong></li>\n<li>Decreased intestinal motility</li>\n<li><strong>Resection of ileocecal valve</strong></li>\n<li><strong>Type 2 diabetes mellitus</strong></li>\n<li><strong>Decreased gastric acid secretion</strong></li>\n</ul>\n<p>Diagnosis is by small bowel cultures or Lactulose hydrogen breath test which shows more than <strong>20ppm </strong>of hydrogen. Treatment is with an antibiotic like <strong>rifaximin</strong>. </p>\n<p>Other Options: </p>\n<p>Option A:<strong> Bile irritation</strong> to the intestinal walls presents with <strong>secretory</strong> <strong>diarrhoea</strong> that occurs even at night. However, the presence of a positive lactulose hydrogen breath test makes SIBO more likely in this case.</p>\n<p>Option C: Dumping syndrome occurs in patients post <strong>Roux en Y jejunal </strong>bypass due to direct bypass to the jejunum which leads to symptoms of bloating and abdominal pain. However a positive lactulose hydrogen breath test makes SIBO more likely in this case.</p>\n<p>Option D: Increased colonic motility is protective and decreases the incidence of SIBO. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0301",
      "difficulty": "hard"
    },
    {
      "text": "A 22-year-old man presented with nausea, watery diarrhea and bloating following the consumption of skimmed milk. Which of the following is the most likely cause of this patient's condition?",
      "choices": [
        {
          "id": 1,
          "text": "Pancreatic enzyme deficiency"
        },
        {
          "id": 2,
          "text": "Immune mediated enterocyte damage"
        },
        {
          "id": 3,
          "text": "Brush border enzyme deficiency"
        },
        {
          "id": 4,
          "text": "Luminal bacterial overgrowth"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This patient with crampy abdominal pain, bloating and water diarrhea following the consumption of <strong>skimmed milk</strong> is most likely <strong>lactose intolerant</strong> with a <strong>brush border enzyme deficiency</strong> (ie. <strong>Lactase</strong>).&nbsp;</p>\n<p><strong>Lactase </strong>is a <strong>brush border enzyme</strong> that <strong>hydrolyzes lactose into glucose and galactose</strong>. In lactase deficiency, patients have great variability in clinical symptoms, depending on both the severity of lactase deficiency and the amount of lactose ingested.</p>\n<p>Lactose intolerance is a common cause of <strong>adult-onset diarrhea</strong> caused by malabsorption that affects individuals aged<strong> 20 to 40.</strong> &nbsp;It has been described throughout the world, with significant variations amongst groups.</p>\n<p><strong>Lactose</strong> is converted to <strong>glucose</strong> and <strong>galactose</strong> <strong>by</strong> intestinal <strong>lactase</strong> on the brush border of the duodenum. As the osmotic burden of undigested lactose moves through the intestines, it <strong>draws water</strong> into the lumen and <strong>shortens transit time</strong>. &nbsp;Colonic bacteria also ferment lactose, producing short-chain fatty acids and <strong>hydrogen gas</strong> (bloating).</p>\n<p>Foods that are high in lactose include milk (12 g/cup), ice cream (9 g/cup), and cottage cheese (8 g/cup). Aged cheese has lower lactose content. Most people can tolerate up to 12g of lactose a day without significant symptoms.</p>\n<p><strong>Yogurt</strong> is the least likely to cause symptoms of lactose intolerance. It contains<strong> lactobacillus that produces lactase</strong> and is generally well tolerated.</p>\n<p>For patients with <strong>inconclusive</strong> <strong>diagnosis</strong>, a <strong>lactose breath hydrogen test</strong> can be performed.</p>\n<p>The goal of treatment in patients with isolated lactase deficiency is achieving patient comfort through the <strong>elimination of dietary lactose </strong>or <strong>supplementation</strong> with lactase.</p>\n<p>Other options :</p>\n<p>Option A : Patients with <strong>exocrine pancreatic insufficiency</strong> have defective digestion of fat and protein with symptoms of steatorrhea. Patients with pancreatic insufficiency have risk factors such as cystic fibrosis, <strong>chronic pancreatitis</strong> or a history of bowel or pancreatic resection.</p>\n<p>Option D : <strong>Luminal bacterial overgrowth</strong> is seen in small intestinal bacterial overgrowth (<strong>SIBO</strong>) which occurs when <strong>colonic bacteria migrate into the small intestine</strong>. <strong>Diarrhea</strong> in SIBO is most likely <strong>oily/greasy</strong>. It is usually associated with patients with fistulas or a motility disorder. This patient did not present with symptoms of greasy stool nor did he have any underlying disorder making this diagnosis unlikely.&nbsp;</p>\n<p>Option C : <strong>Immune mediated damage</strong> to the <strong>enterocytes</strong> are seen in autoimmune conditions such as <strong>Celiac disease</strong> which leads to damage to the enterocytes as well as <strong>villous atrophy.</strong> Patients with this disease usually have <strong>foul</strong> <strong>smelling</strong> stools or <strong>greasy</strong> <strong>stools</strong> which is not seen in this patient making this diagnosis unlikely.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0425",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about Intestinal lymphangiectasia?",
      "choices": [
        {
          "id": 1,
          "text": "Can cause protein loss "
        },
        {
          "id": 2,
          "text": "Associated with fat malabsorption"
        },
        {
          "id": 3,
          "text": "Disorder of mucosal absorption"
        },
        {
          "id": 4,
          "text": "Can occur secondarily due to lymphoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Intestinal lymphangiectasia</strong> is not primarily a <strong>disorder of mucosal absorption</strong>, as the issue lies in the lymphatics (post-mucosal absorption) rather than the intestinal mucosa. Hence, Option C is a false statement.<br /><br />Intestinal lymphangiectasia involves the <strong>dilation</strong> of<strong> intestinal lymphatic vessels</strong>, leading to <strong>protein loss</strong> and <strong>fat malabsorption</strong> due to <strong>impaired lymphatic drainage.</strong></p>\n<p>The condition can be either <strong>primary</strong> (congenital) or <strong>secondary.</strong> Primary intestinal lymphangiectasia is usually congenital and may be associated with other lymphatic disorders. Secondary causes include conditions that obstruct the lymphatic system, such as <strong>lymphoma</strong>(Option D), filariasis or constrictive pericarditis. </p>\n<p>The primary issue in intestinal lymphangiectasia is the dilation and dysfunction of the intestinal lymphatic vessels. This leads to the leakage of protein-rich lymph into the gastrointestinal tract, causing <strong>protein-losing enteropathy</strong> (option A). There is impaired absorption of fats and fat-soluble vitamins due to the loss of chylomicrons (Option B), which are essential for fat transport.</p>\n<p>Patients typically present with:</p>\n<ul>\n<li>Chronic Diarrhea: Often steatorrhea (fatty stools) due to fat malabsorption.</li>\n<li>Edema: Resulting from protein loss and hypoalbuminemia.</li>\n<li>Weight Loss: Due to malabsorption of nutrients.</li>\n<li>Lymphopenia: Low lymphocyte levels due to the loss of lymphocytes in the gastrointestinal tract.</li>\n</ul>\n<p>Diagnosis is usually confirmed by <strong>endoscopy and biopsy</strong>, showing dilated lymphatic vessels in the mucosa. Laboratory tests typically reveal hypoalbuminemia, hypoproteinemia, and lymphopenia.</p>\n<p>Management focuses on:</p>\n<ul>\n<li>Dietary Modification: A low-fat, high-protein diet supplemented with medium-chain triglycerides (MCTs) to reduce lymphatic pressure.</li>\n<li>Medical Therapy: <strong>Octreotide,</strong> a somatostatin analogue, can be used to reduce lymphatic leakage and manage symptoms.</li>\n<li>Surgical Intervention: In cases where lymphatic obstruction is localized, surgery may be required to relieve the obstruction.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6642",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false regarding IPEX syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Males are primarily affected"
        },
        {
          "id": 2,
          "text": "It is an X-linked dominant disorder"
        },
        {
          "id": 3,
          "text": "It includes autoimmune endocrinopathy"
        },
        {
          "id": 4,
          "text": "It is associated with IBD"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>IPEX syndrome </strong>(Immune dysregulation, <strong>Polyendocrinopathy</strong>, Enteropathy, X-linked) is an <strong>X-linked recessive disorder </strong>(<strong>not </strong>X-linked dominant), primarily affecting <strong>males </strong>(Option A).</p>\n<p>It is caused by mutations in the <strong>FOXP3 gene</strong>. The syndrome manifests early in life with symptoms like <strong>Type 1 diabetes, Eczema, </strong>and<strong> </strong>autoimmune<strong> enteropathy</strong>. It often leads to severe immune system dysregulation.</p>\n<p>It is also a primary genetic disorder associated with autoimmune conditions like <strong>inflammatory bowel disease</strong>(Option D).</p><hr><h3>Related Pearl: Non–HLA Genes Associated with Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Gene involved</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>FOXP3</strong></p>\n</td>\n<td>\n<p>IPEX (an acronym for immune dysregulation, polyendocrinopathy, enteropathy, X-linked).</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>AIRE</strong></p>\n</td>\n<td>\n<p>Autoimmune polyendocrinopathy syndrome type 1 (APS-1).</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>PTPN22</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis</p>\n<p>Type I DM</p>\n<p>IBD</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>IL23R</strong></p>\n</td>\n<td>\n<p>IBD</p>\n<p>Psoriasis</p>\n<p>Ankylosing spondylitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CTLA4</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis</p>\n<p>Type I Diabetes mellitus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>L2RA</strong></p>\n</td>\n<td>\n<p>Type I Diabetes mellitus</p>\n<p>Multiple sclerosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>NOD2</strong></p>\n<p><strong>ATG16</strong></p>\n</td>\n<td>\n<p>Inflammatory bowel disease (IBD)&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>IRF5, IFIH1</strong></p>\n</td>\n<td>\n<p>Systemic lupus erythematosus (SLE)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6650",
      "difficulty": "medium"
    }
  ]
}